Introduction
Todxil PR 600 is a prolonged-release NSAID tablet from Astemax Biotech, providing sustained etodolac delivery for all-day pain and inflammation control.
Composition
Each extended-release tablet contains Etodolac 600 mg in a matrix formulation that ensures slow dissolution over 8-12 hours, achieving peak plasma levels around 6 hours post-dose with >80% bioavailability.
Todxil PR 600 excels in the ortho segment for managing chronic joint and musculoskeletal conditions with its prolonged-release etodolac formulation.
Orthopedic Applications
It’s widely used for osteoarthritis and rheumatoid arthritis to reduce joint pain, stiffness, and swelling, improving mobility; also effective post-orthopedic surgery (e.g., knee/hip replacement), acute gouty arthritis, low back pain, painful shoulder, tendinitis, bursitis, and sports injuries like sprains.
Uses
Indicated for osteoarthritis, rheumatoid arthritis, and acute painful shoulder, offering once-daily dosing to manage chronic joint pain, stiffness, and swelling effectively.
Mechanism
Etodolac selectively inhibits COX-2 enzymes to suppress prostaglandins, reducing inflammation and nociception while minimizing GI ulceration risk compared to non-selective NSAIDs; half-life extends to 8.4 hours for prolonged relief.
